Home/Filings/4/0000950170-24-028609
4//SEC Filing

PASSERI DANIEL R 4

Accession 0000950170-24-028609

CIK 0001645460other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:00 PM ET

Size

5.3 KB

Accession

0000950170-24-028609

Insider Transaction Report

Form 4
Period: 2024-03-06
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2024-03-06+400,000400,000 total
    Exercise: $1.94Exp: 2034-03-05Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024.

Documents

1 file

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0001190121

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:00 PM ET
Size
5.3 KB